HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Choon-Sik Park Selected Research

Bronchial Spasm

11/2012CD55 polymorphisms and risk of aspirin‑exacerbated respiratory disease.
5/2012Association study between TRIM26 polymorphisms and risk of aspirin-exacerbated respiratory disease.
4/2012Potential association of DCBLD2 polymorphisms with fall rates of FEV(1) by aspirin provocation in Korean asthmatics.
1/2012A case of propofol-induced oropharyngeal angioedema and bronchospasm.
10/2011Bronchospasm and anaphylactic shock following lidocaine aerosol inhalation in a patient with butane inhalation lung injury.
10/2011Association of the variants in AGT gene with modified drug response in Korean aspirin-intolerant asthma patients.
8/2011Lack of association between CD58 genetic variations and aspirin-exacerbated respiratory disease in a Korean population.
1/2010Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Choon-Sik Park Research Topics

Disease

124Asthma (Bronchial Asthma)
07/2015 - 06/2003
26Inflammation
11/2015 - 08/2003
24Hypersensitivity (Allergy)
07/2015 - 02/2006
9Nasal Polyps (Nasal Polyp)
12/2014 - 01/2011
8Bronchial Spasm
11/2012 - 01/2010
7Airway Obstruction (Choking)
07/2013 - 01/2005
7Pneumonia (Pneumonitis)
04/2013 - 03/2004
4Infection
11/2015 - 09/2005
4Lung Neoplasms (Lung Cancer)
11/2015 - 03/2011
4Idiopathic Pulmonary Fibrosis
08/2013 - 08/2009
3Chronic Obstructive Pulmonary Disease (COPD)
04/2014 - 06/2011
3Obesity
01/2014 - 11/2008
3Interstitial Lung Diseases (Interstitial Lung Disease)
04/2013 - 08/2009
3Fibrosis (Cirrhosis)
01/2012 - 08/2009
3Airway Remodeling
07/2011 - 01/2006
3Emphysema
04/2010 - 11/2007
3Eosinophilia
11/2007 - 08/2003
2Pulmonary Eosinophilia (Eosinophilic Pneumonia)
01/2014 - 04/2013
2Cough
02/2013 - 06/2004
2Edema
01/2012 - 03/2004
2Anaphylaxis (Anaphylactic Shock)
01/2012 - 10/2011
2Polyps
01/2012 - 01/2012
2Urticaria (Hives)
10/2011 - 12/2005
2Sinusitis
10/2011 - 01/2010
2Lung Injury
10/2011 - 01/2010
2Hyperplasia
07/2011 - 01/2005
2Tuberculosis (Tuberculoses)
04/2011 - 02/2006
2Neoplasms (Cancer)
04/2011 - 03/2011
2Neoplasm Metastasis (Metastasis)
03/2011 - 01/2005
2Acute Lung Injury
01/2010 - 03/2004
1Contact Dermatitis (Eczema, Contact)
07/2015

Drug/Important Bio-Agent (IBA)

62Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2015 - 09/2004
18Immunoglobulin E (IgE)IBA
05/2013 - 06/2003
13CytokinesIBA
01/2014 - 08/2003
8Messenger RNA (mRNA)IBA
02/2011 - 02/2005
7Methacholine Chloride (Methacholine)FDA Link
07/2014 - 06/2004
6Genetic Markers (Genetic Marker)IBA
07/2014 - 01/2009
6Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA
07/2011 - 07/2003
5Proteins (Proteins, Gene)IBA
04/2014 - 08/2005
5Interleukin-4 (Interleukin 4)IBA
01/2013 - 01/2004
4DNA (Deoxyribonucleic Acid)IBA
07/2015 - 01/2005
4Carrier Proteins (Binding Protein)IBA
12/2014 - 01/2011
4Biological Markers (Surrogate Marker)IBA
04/2014 - 04/2011
4Interleukin-8 (Interleukin 8)IBA
04/2012 - 01/2004
4EnzymesIBA
06/2011 - 01/2004
4Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2010 - 07/2003
4Interleukin-13IBA
08/2009 - 01/2005
4OzoneIBA
01/2006 - 01/2004
3InterleukinsIBA
11/2015 - 10/2005
3Adrenal Cortex Hormones (Corticosteroids)IBA
09/2014 - 06/2004
3OvalbuminIBA
01/2014 - 02/2008
31-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
01/2014 - 10/2005
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
05/2012 - 01/2010
3Interleukin-2 (IL2)IBA
05/2011 - 01/2004
3Interleukin-5 (Interleukin 5)IBA
07/2010 - 08/2003
2SmokeIBA
07/2015 - 10/2010
2NF-kappa B (NF-kB)IBA
03/2014 - 03/2010
2Vehicle Emissions (Emissions, Vehicle)IBA
01/2014 - 10/2005
2CCR3 ReceptorsIBA
01/2014 - 01/2005
2Air Pollutants (Pollutants, Air)IBA
01/2014 - 01/2006
2CalciumIBA
10/2013 - 01/2010
2RNA (Ribonucleic Acid)IBA
05/2013 - 02/2008
2AntigensIBA
01/2012 - 01/2009
2montelukast (Singulair)FDA Link
10/2011 - 01/2010
2GTP-Binding Proteins (G-Protein)IBA
04/2011 - 11/2004
2Adenocarcinoma of lungIBA
04/2011 - 03/2011
2ChemokinesIBA
04/2011 - 11/2007
2Transcription Factors (Transcription Factor)IBA
12/2010 - 10/2006
2Neurotransmitter Agents (Neurotransmitter)IBA
07/2010 - 06/2010
2Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
03/2010 - 03/2004
2salicylhydroxamic acid (SHAM)IBA
01/2010 - 02/2008
2Leukotriene Receptors (Leukotriene Receptor)IBA
01/2010 - 09/2004
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2010 - 03/2004
2PPAR gammaIBA
10/2009 - 07/2009
2Protein Isoforms (Isoforms)IBA
05/2009 - 01/2004
2Prostaglandin H2 Thromboxane A2 ReceptorsIBA
04/2009 - 08/2003
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2007 - 02/2004
2AutoantibodiesIBA
01/2007 - 12/2006
2Interleukin-10 (Interleukin 10)IBA
02/2006 - 01/2004
2Chemokine CCL24IBA
11/2005 - 01/2005
2GlucocorticoidsIBA
09/2005 - 08/2005
2AllergensIBA
09/2005 - 01/2004
2Nitric Oxide Synthase (NO Synthase)IBA
03/2004 - 01/2004
1urushiolIBA
07/2015
1fibrinogen gamma'IBA
04/2014
1beta 2-Glycoprotein I (Apolipoprotein H)IBA
04/2014
1Immunoglobulin M (IgM)IBA
04/2014
1retinoic acid receptor alphaIBA
04/2014
1Complement Factor B (Factor B)IBA
04/2014
1FibrinIBA
04/2014
1gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA
04/2014
1Immunoglobulin G (IgG)IBA
04/2014
1tyrosyl-DNA phosphodiesteraseIBA
04/2014
1Transferrin (beta 2 Transferrin)IBA
04/2014
1hydroxide ionIBA
01/2014
1Carbon MonoxideIBA
01/2014
1AngiopoietinsIBA
01/2014
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
08/2013

Therapy/Procedure

2Aftercare (After-Treatment)
08/2012 - 08/2005
1Intraperitoneal Injections
01/2014